Superoxide flashes, reactive oxygen species, and the mitochondrial permeability transition pore: Potential implications for hematopoietic stem cell function

Current Opinion in Hematology

Volumn 18, Issue 4, 2011, Pages 208-213

  Mantel, Charlie ^a   Messina Graham, Steven V ^a   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hematopoietic stem cell; hypoxia; mitochondrial permeability transition pore; reactive oxygen species; transplantation

Indexed keywords

CYCLOPHILIN D; HYDROGEN PEROXIDE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT3 PROTEIN; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATG7 GENE; ENERGY YIELD; ENZYME INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; MITOCHONDRIAL PERMEABILITY; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REDUCTION KINETICS; REPERFUSION INJURY; RESPIRATORY CHAIN; ROS INDUCED ROS RELEASE; SIGNAL TRANSDUCTION; SUPEROXIDE FLASH; THROMBOCYTOPENIA;

ANIMALS; APOPTOSIS; HEMATOPOIETIC STEM CELLS; HUMANS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 79958780643     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283475ffe     Document Type: Article

References (62)

1. Clement AM, Long JA. Air-breathing adaptation in a marine Devonian lungfish. Biol Lett 2010; 6:509-512.
2. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford, UK: Clarendon Press; 2007.
3. Sattler M, Verma S, Shrikhande G, et al. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 2000; 275:24273-24278. (Pubitemid 30626515)
4. Sauer H, Wartenberg M. Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxid Redox Signal 2005; 7:1423-1434. (Pubitemid 41767977)
5. D'Autré aux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8:813-824.
6. Eliasson P, Jö nsson J-I. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 2010; 222:17-22.
7. Vincent A, Crozatier M. Neither too much nor too little: reactive oxygen species levels regulate Drosophila hematopoiesis. J Mol Cell Biol 2010; 2:74-75.
8. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 2010; 35:505-513.
9. Owusu-Ansah E, Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009; 461:537-541.
10. Yalcin S, Marinkovic D, Mungamuri SK, et al. ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice. EMBO J 2010; 29:4118-4131.
11. Jiang F, Zhang Y, Dusting GJ. NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev 2011; 63:218-242.
12. Wang W, Fang H, Groom L, et al. Superoxide flashes in single mitochondria. Cell 2008; 134:279-290. (Pubitemid 352010332)
13. Sheu S-S, Wang W, Cheng H, Dirksen RT. Superoxide flashes: illuminating new insights into cardiac ischemia/reperfusion injury. Future Cardiol 2008; 4:551-554.
14. Pouvreau S. Superoxide flashes in mouse skeletal muscle are produced by discrete arrays of active mitochondria operating coherently. PLoS One 2010; 5:e13035.
15. Zorov DB, Filburn CR, Klotz LO, et al. Reactive oxygen species (ROS)- induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000; 192:1001-1014.
16. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta 2006; 1757:509-517.
17. Zorov DB, Juhaszova M, Yaniv Y, et al. Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovas Res 2009; 83:213-225.
18. Zhou L, Aon MA, Almas T, et al. Reaction-diffusion model of ROS-induced ROS release in a mitochondrial network. PLoS Comput Biol 2010; 6:e1000657.
19. Parmar K, Mauch P, Vergilio J-A, et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 2007; 104:5431-5436. (Pubitemid 47175697)
20. Oki M, Ando K. Hematopoietic growth factors, cytokines, and bone-marrow microenvironment. Nippon Rinsho 2008; 66:444-452.
21. Silván U,Díez-Torre A, Arluzea J, et al. Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology. Differentiation 2009; 78:159-168.
22. Panchision DM. The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 2009; 220:562-568.
23. Lekli I, Gurusamy N, Ray D, et al. Redox regulation of stem cell mobilization. Can J Physiol Pharmacol 2009; 87:989-995.
24. Holzwarth C, Vaegler M, Gieseke F, et al. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 2010; 11:11.
25. Abdel-Wahab O, Levine RL. Metabolism and the leukemic stem cell. J Exp Med 2010; 207:677-680.
26. Winkler IG, Barbier V, Wadley R, et al. Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches. Blood 2010; 116:375-385.
27. Mohyeldin A, Garzó n-Muvdi T, Quiñones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010; 7:150-161.
28. Simsek T, Kocabas F, Zheng J, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010; 7:380-390.
29. Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 2010 [Epub ahead of print].
30. Zhang C, Jia P, Jia Y, et al. Anoxia, acidosis, and intergenic interactions selectively regulate methionine sulfoxide reductase transcriptions in mouse embryonic stem cells. J Cell Biochem 2011; 112:98-106.
31. Vieira HLA, Alves PM, Vercelli A. Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species. Prog Neurobiol 2011; 93:444-455.
32. Sattler M, Winkler T, Verma S, et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 1999; 93:2928-2935. (Pubitemid 29200783)
33. Mortensen M, Soilleux EJ, Djordjevic G, et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med 2011; 208:1-13.
34. Chen ML, Logan TD, Hochberg ML, et al. Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood 2009; 114:4045-4053.
35. Pollard PJ, Kranc KR. Hypoxia signaling in hematopoietic stem cells: a doubleedged sword. Cell Stem Cell 2010; 7:276-278.
36. Tothova Z, Gilliland DG. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell 2007; 1:140-152. (Pubitemid 47215597)
37. Ito K, Hirao A, Arai F, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004; 431:997-1002. (Pubitemid 39434422)
38. Yalcin S, Zhang X, Luciano JP, et al. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem 2008; 283:25692-25705.
39. Yin CC, Medeiros LJ, Bueso-Ramos CE. Recent advances in the diagnosis and classification of myeloid neoplasms: comments on the 2008 WHO classification. Int J Lab Hematol 2010; 32:461-476.
40. Agrawal M, Garg RJ, Cortes J, et al. Experimental therapeutics for patients with myeloproliferative neoplasias. Cancer 2011; 117:662-676.
41. Heiss S, Erdel M, Gunsilius E, et al. Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case. Hum Pathol 2005; 36:1148-1151. (Pubitemid 41443269)
42. Mahon F-X. JAK the trigger. Oncogene 2005; 24:7125-7126. (Pubitemid 41679274)
43. James C, Ugo V, Casadevall N, et al. A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. Trends Mol Med 2005; 11:546-554. (Pubitemid 41713996)
44. Bacher U, Schnittger S, Kern W, et al. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Ann Hematol 2009; 88:1207-1213.
45. Passamonti F, Elena C, Schnittger S, et al. Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood 2011; 117:2813-2816.
46. Abdel-Wahab O. Genetics of the myeloproliferative neoplasms. Curr Opin Hematol 2011; 18:117-123.
47. Zou H, Yan D, Mohi G. Differential biological activity of disease-associated JAK2 mutants. FEBS Lett 2011; 585:1007-1013.
48. Lufei C, Ma J, Huang G, et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J 2003; 22:1325-1335. (Pubitemid 36362696)
49. Guo Z, Jiang H, Xu X, et al. Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J Biol Chem 2008; 283:1754-1763.
50. Gough DJ, Corlett A, Schlessinger K, et al. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009; 324:1713-1716.
51. Wegrzyn J, Potla R, Chwae Y-J, et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009; 323:793-797.
52. Myers MG. Cell biology. Moonlighting in mitochondria. Science 2009; 323:723-724.
53. Phillips D, Reilley MJ, Aponte AM, et al. Stoichiometry of STAT3 and mitochondrial proteins: implications for the regulation of oxidative phosphorylation by protein-protein interactions. J Biol Chem 2010; 285:23532-23536.
54. Buechner N, Altschmied J, Jakob S, et al. Well known signalling proteins exert new functions in the nucleus and mitochondria. Antioxid Redox Signal 2009; 13:551-558.
55. Inoue S-I, Noda S, Kashima K, et al. Mitochondrial respiration defects modulate differentiation but not proliferation of hematopoietic stem and progenitor cells. FEBS Lett 2010; 584:3402-3409.
56. Darnell JE Jr. STAT3, HIF-1, glucose addiction and Warburg effect. Aging 2010; 2:823-842.
57. Reich NC. STAT3 revs up the powerhouse. Sci Signal 2009; 2:pe61; Blood 2009; 114:1289-1298.
58. Han MK, Song EK, Guo Y, et al. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2008; 2:241-251. (Pubitemid 351298591)
59. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010; 105:771-785.
60. Hosokawa K, Arai F, Yoshihara H, et al. Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction. Biochem Biophys Res Commun 2007; 363:578-583. (Pubitemid 47513670)
61. Hercus TR, Thomas D, Guthridge MA, et al. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 2009; 114:1289-1298.
62. Mantel C, Messina-Graham S, Broxmeyer HE. Upregulation of nascent mitochondrial biogenesis in mouse hematopoietic stem cells parallels upregulation of CD34 and loss of pluripotency: a potential strategy for reducing oxidative risk in stem cells. Cell Cycle 2010; 9:2008-2017.